期刊文献+

紫杉醇加顺铂方案联合同步放疗治疗局部晚期食管癌的临床观察 被引量:8

下载PDF
导出
摘要 目的评价紫杉醇加顺铂方案联合同步放疗治疗食管癌的疗效和不良反应。方法对60例食管癌患者根据不同的治疗方法分为两组,放化组在同时及放疗后共进行4周期的TP方案化疗;化疗用紫杉醇175 mg/m^2,d1、d8,顺铂50 mg/m^2 d1、d8,21天为一周期。单放组行单纯根治性放疗。结果放化组有效率为86.7%,单放组有效率为53.3%,放化组的有效率明显高于单放组(P<0.05);放化组1、2、3年生存率分别为85.3%、60.4%、40.2%,单放组1、2、3年生存率分别为54%、34%、24%,放化组1、2、3年生存率明显高于单放组(P<0.05)。结论 TP方案联合同步放化疗的疗效优于单纯性放疗,可以明显的提高食管癌的疗效和生存率,值得进一步研究。
作者 何建兴
出处 《中国医学创新》 CAS 2011年第22期59-60,共2页 Medical Innovation of China
  • 相关文献

参考文献8

二级参考文献27

  • 1姚卫华,路平,花勤亮,吴洁清,苗战会,刘晶,李小瑞.小剂量顺铂和氟尿嘧啶方案同步放射治疗中晚期食管癌[J].中华放射肿瘤学杂志,2005,14(4):262-264. 被引量:24
  • 2仇红艳.同期放化疗综合治疗食管癌临床疗效观察[J].实用癌症杂志,2005,20(5):527-528. 被引量:24
  • 3乔学英 周道安.中晚期食管癌放射治疗配合卡铂的远期疗效[J].中华放射肿瘤学杂志,1997,6(2):118-119.
  • 4殷蔚伯 刘泰福.肿瘤放射治疗学[M].北京:北京医科大学中国协和医科大学联合出版社,1993.443-475,238-252.
  • 5Katlic MR, Wildins EW, Grillo HC. Three decades of treatment of esophageal squamous carcinoma at the Massahutts Genceral Hospital[J]. J Thorac Cardivasc Surg, 1990,99(5) :929.
  • 6Polee MB,Eskens FA,Van der Burg ME,et al. Phase Ⅱ study of hi-weekly administration of paclitaxel and cisplatin in patients with advanced esophageal cancer[J]. Br J Cancer,2002,86(5) :669.
  • 7Safrah H, Akeman P, Cioffi W, et al. Paelitaxel and concurrent radioation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction[J]. Semin Radiat Oncol, 1999,9(Suppl1) : 53.
  • 8韩企夏.食管癌[A].见:汤钊猷主编.现代肿瘤学:第2版[C].上海:上海医科大学出版社,2000.658~694.
  • 9肖泽芬.食管癌[A].殷蔚伯谷铣之.肿瘤放射治疗学[C].北京:中国医科大学中国协和医科大学出版社,2002.598-622.
  • 10刘振化.食管癌肿瘤预后学[M].北京科学技术文献出版社,1995.430.

共引文献116

同被引文献56

  • 1刘俊,吕长兴,王家明.同步放化疗治疗不能手术的食管癌临床结果[J].中华放射肿瘤学杂志,2006,15(3):185-187. 被引量:89
  • 2] Chunwei F, Qingzeng N, jianliang L, et al. Cervical esophagogas- tric anastomosis with a new stapler in she surgery of esophageal carcinoma [ J ]. Eur J Cardiothorac Surg,2005,28 (2) :291 - 295.
  • 3Takeshita K, Sekita Y, Tani M. Medium - and long - term resuhs of jejunal pouch reconstruction after a total and proximal gastrec- tomy[ J ]. Surg Toty,2007,37 (9) :754 - 761.
  • 4黄海欣,李桂生,黄东宁,宁四海,王占宇.不同化疗方案配合放疗治疗局部晚期鼻咽癌的临床观察[J].中国肿瘤临床,2007,34(16):947-948. 被引量:6
  • 5Herskovic A,Marts K,Alsarraf M,et al.Combined chemotherapy and radiotherapy compared with radiotherapy along in patients with esophageal cancer[J].N Eng J Med,1992,326(24):1593-1598.
  • 6Endo M,Yoshino K,Kawano T,et al.Clinieopathologic analysis of lymph node metestasis in surgically resected superficial cancer of the thoracic esophagus[J].Dis Esophagus,2000,13(2):125-129.
  • 7Metges JP.Neo-adjuvant radiochemotherapy for esophageal cancer(J).Gastroenterol Clin Biol,2006,30(1):110-113.
  • 8Bonnetain F,Bouche O,Michel P,et al.A comparative longtitu-dinal quality of life study using the Spitzer quality of life indexin a randomized multicenter phaseⅢtrial(FFCD102):chemo-radiation followed by surgery compared with Chemoradiation a-lone in locally advanced squamous resectable thorable thoracicesophageal cancer(J).Annncol,2006,17(5):827-834.
  • 9Damodaran S,Bellavia T,Sait SN,et al.Acute myeloid leukemia secondary to oxaliplatin treatment for esophageal cancer[J].Clin Colorectal Cancer,2012,11(2):151-154.
  • 10Liu HF,Hu HC,Chao JI.Oxaliplatin down-regulates survivin by p38 MAP kinase and proteasome in human colon cancer cells[J].Chem Biol Interact,2010,188(3):535-545.

引证文献8

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部